9 and while I believe we’ll see a fairly dramatic change in the valuations that companies are able to secure as compared to the previous five years, I don’t foresee a material reduction in the overall investment dollars / the number of investments.” “Whatever complaints may be laid at the feet of Government and the Israel Innovation Authority (“IIA”) – in the field of technology funding, research and support, Israel is a world leader – just look at the EU and the US which are positively backward in comparison,” says S. Horowitz’s Clifford Davis. “We should be proud of the support (of whatever political hue) the Govt and IIA has given – they have been the strategic super growth compound for the bio-tech field in Israel – proof of this can be looked at other countries failure in this regard.” Gornitzky’s Mei-Zahav adds: “The IIA provides Israeli companies that have developed new and innovative technologies to receive development funds for their technology; specific new programs allow the companies to receive funding relatively quickly and match other private investments.” Copelovitz at Lipa Meir is also positive. “The Israel Government remains highly supportive of this sector. One particular jurisdiction also of interest, worth mentioning, is that of Finland, with the launch of the life sciences collaboration between the Israel Innovation Authority and Business Finland. What with both countries having leading innovation economies, and being global leaders in digital health, there exists an incredible potential for collaborative efforts.” Investment needs differ at every stage of growth for life science and healthcare companies. There are many avenues available to raise capital at various stages, each with its own benefits and considerations. Savvy founders and start-up leaders should understand which asset class can offer thebest opportunity toadvanceandsupport their company’s success. Across all sectors - therapeutics, diagnostics, tools, medical devices and digital health - the approach you take today to create your syndicate of investors will impact all future funding rounds. Incubators (sometimes called accelerators) can be great resources at the earliest stages of a company’s development. While the long-term outlook looks extremely strong, how has the Government been helping?
RkJQdWJsaXNoZXIy MjgzNzA=